4.5 Review

Role of noncoding RNAs and untranslated regions in cancer: A review

Journal

MEDICINE
Volume 101, Issue 33, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000030045

Keywords

cancer; long non-coding RNAs; microRNAs; non-coding RNAs; untranslated regions

Funding

  1. National Natural Science Foundation of China [82060661, 81660751, 81660151]
  2. Jiangxi Provincial Natural Science Foundation of China [20212BAB206092]

Ask authors/readers for more resources

This review discusses the role and importance of ncRNAs in cancer, including miRNAs, lncRNAs, circRNAs, and UTRs. ncRNAs function as tumor suppressors or oncogenes, interfering with different axes and pathways involved in cancer progression, with their characteristic expression allowing them to be used as biomarkers for early diagnosis and therapeutic candidates. Furthermore, there is a complex network of interactions between ncRNAs, which is crucial for cancer diagnosis and treatment.
Cancer is one of the most prevalent diseases worldwide, and poses a threat to human health. Noncoding RNAs (ncRNAs) constitute most transcripts, but they cannot be translated into proteins. Studies have shown that ncRNAs can act as tumor suppressors or oncogenes. This review describes the role of several ncRNAs in various cancers, including microRNAs (miRNAs) such as the miR-34 family, let-7, miR-17-92 cluster, miR-210, and long noncoding RNAs (lncRNAs) such as HOX transcript antisense intergenic RNA (HOTAIR), Metastasis associated lung adenocarcinoma transcript 1 (MALAT1), H19, NF-kappa B-interacting lncRNA (NKILA), as well as circular RNAs (circRNAs) and untranslated regions (UTRs), highlighting their effects on cancer growth, invasion, metastasis, angiogenesis, and apoptosis. They function as tumor suppressors or oncogenes that interfere with different axes and pathways, including p53 and IL-6, which are involved in the progression of cancer. The characteristic expression of some ncRNAs in cancer also allows them to be used as biomarkers for early diagnosis and therapeutic candidates. There is a complex network of interactions between ncRNAs, with some lncRNAs and circRNAs acting as competitive endogenous RNAs (ceRNAs) to decoy miRNAs and repress their expression. The ceRNA network is a part of the ncRNA network and numerous ncRNAs work as nodes or hubs in the network, and disruption of their interactions can cause cancer development. Therefore, the balance and stabilization of this network are important for cancer diagnosis and treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available